Search

Author/Creator Howes, Angela

1. Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. Issue 13 (9th November 2020)

Authors:
Fraser, Graeme A.M.; Chanan-Khan, Asher; Demirkan, Fatih; Santucci Silva, Rodrigo; Grosicki, Sebastian; Janssens, Ann; Mayer, Jiri; Bartlett, Nancy L.; Dilhuydy, Marie-Sarah; Loscertales, Javier; Avigdor, Abraham; Rule, Simon; Samoilova, Olga; Pavlovsky, Miguel A.; Goy, Andre; Mato, Anthony; Hall...
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 13(2020)
Page Start:
3188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. Issue 2 (February 2016)

Authors:
Chanan-Khan, Asher; Cramer, Paula; Demirkan, Fatih; Fraser, Graeme; Silva, Rodrigo Santucci; Grosicki, Sebastian; Pristupa, Aleksander; Janssens, Ann; Mayer, Jiri; Bartlett, Nancy L; Dilhuydy, Marie-Sarah; Pylypenko, Halyna; Loscertales, Javier; Avigdor, Abraham; Rule, Simon; Villa, Diego; Samoil...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 2(2016:Feb.)
Page Start:
200
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study. (13th March 2018)

Authors:
Huang, Xiaojun; Qiu, Lugui; Jin, Jie; Zhou, Daobin; Chen, Xiequn; Hou, Ming; Hu, Jianda; Hu, Yu; Ke, Xiaoyan; Li, Junmin; Liang, Yingmin; Liu, Ting; Lv, Yue; Ren, Hanyun; Sun, Aining; Wang, Jianmin; Zhao, Chunting; Salman, Mariya; Sun, Steven; Howes, Angela
Journal:
Cancer medicine
Issue:
Volume 7:Number 4(2018:Apr.)
Page Start:
1043
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study. Issue 9 (2nd September 2018)

Authors:
Cramer, Paula; Fraser, Graeme; Santucci-Silva, Rodrigo; Grosicki, Sebastian; Dilhuydy, Marie-Sarah; Janssens, Ann; Loscertales, Javier; Rule, Simon; Goy, Andre; Traina, Shana; Chan, Eric K. H.; Diels, Joris; Sengupta, Nishan; Mahler, Michelle; Salman, Mariya; Howes, Angela; Chanan-Khan, Asher
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 9(2018)
Page Start:
2075
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations. Issue 7 (July 2019)

Authors:
Soumerai, Jacob D; Ni, Ai; Darif, Mohamed; Londhe, Anil; Xing, Guan; Mun, Yong; Kay, Neil E; Shanafelt, Tait D; Rabe, Kari G; Byrd, John C; Chanan-Khan, Asher A; Furman, Richard R; Hillmen, Peter; Jones, Jeffrey; Seymour, John F; Sharman, Jeffrey P; Ferrante, Lucille; Mobasher, Mehrdad; Stark, Th...
Journal:
Lancet
Issue:
Volume 6:Issue 7(2019)
Page Start:
e366
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The HELIOS trial protocol: a Phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia. (January 2015)

Authors:
Hallek, Michael; Kay, Neil E; Osterborg, Anders; Chanan-Khan, Asher A; Mahler, Michelle; Salman, Mariya; Wan, Ying; Sun, Steven; Zhuang, Sen Hong; Howes, Angela
Journal:
Future oncology
Issue:
Volume 11:Number 1(2015)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The HELIOS trial protocol: a Phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia. (January 2015)

Authors:
Hallek, Michael; Kay, Neil E; Osterborg, Anders; Chanan-Khan, Asher A; Mahler, Michelle; Salman, Mariya; Wan, Ying; Sun, Steven; Zhuang, Sen Hong; Howes, Angela
Journal:
Future oncology
Issue:
Volume 11:Number 1(2015)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗